Cvs Share Discussion Threads

[stuarti10] 30/12/2024 15:51

Yeah, just waiting until the CMA overhang clears then I think it will progress nicely

[spyder] 30/12/2024 13:35

Anyone else out there following this company?

[thaiger] 05/12/2024 18:49

Strange you can buy at 856p and after hour trade sell at 865p!?!

[waldron] 20/11/2024 07:59

Dividend

Subject to shareholder approval at the AGM, CVS intends to pay its previously announced final dividend of 8.0 pence per ordinary share on 29 November 2024 to holders on the register as at 1 November 2024. The ex-dividend date was 31 October 2024.

Outlook

Whilst the Board remains mindful of headwinds in the UK, the fundamental need for high quality veterinary care remains strong, the expansion into Australia is progressing well and CVS remains well positioned to deliver attractive growth in shareholder value over the medium term.



The recently announced UK government budget changes will result in a significant increase in employment costs with effect from April 2025. Whilst these increases will only apply in the final quarter of this financial year, the annualised impact to the year ending 30 June 2026 is estimated to be £8m from the national insurance scheme changes. The Group expects to substantially mitigate these through growth, efficiencies and purchasing synergies in Australia.



The Board remains confident in the Group's ability to deliver full year 2025 results in line with market expectations.

[bulltradept] 10/11/2024 20:07

£8.00?

[stuarti10] 08/11/2024 14:11

How far does this drop until to April then?

[la forge] 27/10/2024 02:35

CVS, one of the UK's leading providers of integrated veterinary services, announces that its Annual General Meeting ("AGM") will be held at the offices of Linklaters LLP at One Silk Street, London EC2Y 8HQ on 20 November 2024 at 11:00am.

[wad collector] 26/10/2024 20:43

Those AI summaries just list facts , there is no interpretation nor opinion.

[waldron] 08/10/2024 07:19

CVS Group (LON:CVSG) Shares Cross Above 200 Day Moving Average - Time to Sell?
Written by MarketBeat
October 4, 2024


CVS Group plc (LON:CVSG - Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,054.38 ($14.10) and traded as high as GBX 1,124 ($15.03). CVS Group shares last traded at GBX 1,064 ($14.23), with a volume of 349,914 shares changing hands.
Get CVS Group alerts:


Wall Street Analyst Weigh In

Separately, Berenberg Bank reissued a "buy" rating and issued a GBX 2,370 ($31.70) price objective on shares of CVS Group in a research note on Thursday, July 25th.


The company has a quick ratio of 0.90, a current ratio of 1.09 and a debt-to-equity ratio of 110.48. The firm has a market capitalization of £760.44 million, a P/E ratio of 2,905.56, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The company's 50 day moving average is GBX 1,116.43 and its 200-day moving average is GBX 1,054.44.


CVS Group Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, November 29th. Stockholders of record on Thursday, October 31st will be issued a dividend of GBX 8 ($0.11) per share. This is an increase from CVS Group's previous dividend of $7.50. The ex-dividend date of this dividend is Thursday, October 31st. This represents a dividend yield of 0.71%. CVS Group's payout ratio is currently 2,222.22%.


Insider Activity at CVS Group

In other CVS Group news, insider Richard Gray bought 1,600 shares of the firm's stock in a transaction dated Wednesday, July 10th. The stock was bought at an average cost of GBX 1,019 ($13.63) per share, with a total value of £16,304 ($21,808.45). 5.83% of the stock is currently owned by insiders.



CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.

[bulltradept] 08/10/2024 06:37

Any link please?

[solsticefire] 06/10/2024 17:28

Big article in the sunday times today.

[c3479z] 03/10/2024 21:00

according to the Times, the committee appointed to advise the CMA contains several who favour independent vet practice over corporates and this group is a majority.

[wad collector] 03/10/2024 20:30

Only news I can find for today's drop which I think unconnected; fri=om the Veterinary times

Revenues rise for CVS as company confirms cooperation with CMACVS income has risen by almost 10% during the past 12 months with the company generating revenues of more than £647 million.

The boss of CVS has revealed how the company has been supporting the Competition and Markets Authority (CMA) ongoing market investigation of the small animal veterinary sector.

Chief executive Richard Fairman was speaking following the release of CVS’ year-end results last week, which showed a revenue increase of nearly 10% to more than £647 million during the past 12 months.

This was despite a number of challenges during that period, including a cyberattack and the subsequent work to migrate the bulk of its UK practices to a cloud-based PMS, as well as the impact on the business of the ongoing CMA investigation.

Proactive engagement
Mr Fairman said: “We have proactively tried to engage with the CMA throughout its process and that has continued following the announcement of the market investigation in May.

“Myself, Paul [Higgs] and Robin [Alfonso], along with other members of our senior team, asked for a teaching session with the CMA, and we met the panel and helped them better understand the sector, better understand CVS and what we are trying to achieve. We also wanted to help them understand some of the challenges we will face in our sector.”

Mr Fairman also revealed that the CMA had already conducted two site visits at CVS practices – a first opinion site and also a small referral hospital.

‘Great opportunity’
Mr Fairman added: “That was a great opportunity for our teams to showcase what they do and also to talk them through some of the challenges as well.

“We have also talked about the requirements for new legislation and if the CMA can help influence a new Veterinary Surgeons Act then I think that could be beneficial.”

In line with the other corporate groups, CVS only made limited UK practice acquisitions last year with £12.7 million spent on five practices as the company continues to focus its buying activity on the Australian market, where 22 practices were acquired for a total of £82.5 million.

Further growth
While UK acquisitions have tailed off, Mr Fairman pointed to the multimillion-pound investments made across CVS’ UK estate, as well as the continued development of initiatives such as its clinical governance framework and the new graduate programme, which attracted 170 new graduates last year.

He said: “I am privileged to lead a team of outstanding colleagues who care passionately about our clients and their animals under our care.

“I would like to take this opportunity to thank them all for their commitment and dedication, and I look forward to delivering further growth in 2025 and beyond.”

[bulltradept] 03/10/2024 14:16

Now that's not nice.

[wad collector] 27/9/2024 16:00

Or maybe the irrationality of human beings?

[undervaluedassets] 27/9/2024 13:43

agreed algo games.

[bulltradept] 27/9/2024 13:39

Be back £11.30 soon enough.

[bulltradept] 27/9/2024 13:36

Algo games.

[undervaluedassets] 27/9/2024 04:02

Somewhat baffled by yesterday.

The results were .. well horrible ...

EPS of 8p down from 58p..Good golly gosh.. My sharescope had 90p penicilled for EPS

But then the shares charged..

Go figure

I am not complaining.. Had my finger on the sell button but relented.. Glad I did

[bulltradept] 26/9/2024 07:20

We did, but then rejected on low volume..

[wad collector] 26/9/2024 07:20

Well that drop didn't last long ;about 15 minutes! Guess the lower numbers were all in the price.

[wad collector] 26/9/2024 07:00

I think we are about to see a sharp drop.Again.

[waldron] 26/9/2024 06:56

Latest Dividends

Summary Previous dividend Next dividend

Status Paid Declared

Type Final Final

Per share 7.5p 8p

Declaration date 21 Sep 2023 (Thu) 26 Sep 2024 (Thu)

Ex-div date 02 Nov 2023 (Thu) 31 Oct 2024 (Thu)

Pay date 08 Dec 2023 (Fri) 29 Nov 2024 (Fri)

DIVIDENDMAX

[waldron] 26/9/2024 06:46

Outlook

I was pleased with the underlying trading performance in the financial year to 30 June 2024 notwithstanding the short-term operational challenges of the cyber incident and the resulting accelerated rollout of a new practice management system.

I am excited by the opportunity ahead for CVS through continued investment in the UK and through our expansion in Australia. With continued good operating cash conversion and headroom in both our loan facility and leverage target, we are well placed to complete further Australian acquisitions in 2025.

Whilst we continue to be mindful of cost of living pressures on household incomes, we are confident that our strategy for growth focused on our people and on high-quality clinical care positions us well to deliver further growth over the coming years.

Our clients continue to seek high-quality care and we are fortunate to employ such a talented team of colleagues who are passionate at providing the best possible care to our clients and to their animals. I look forward to sharing further success with them in 2025 and beyond.

Richard Fairman

Chief Executive Officer

26 September 2024

[babbler] 26/9/2024 06:41

Eeek won't be pretty today